Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market

TheMotleyFool

0 0

How Gilead's and Merck's Surprise Partnership Will Shake Up the HIV Market

Gilead Sciences (NASDAQ: GILD) and Merck (NYSE: MRK) have historically been rivals in the HIV drug market. Now, though, the big companies are teaming up to develop a long-acting HIV therapy. In this Motley Fool Live video recorded on March 17, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how Gilead and Merck's surprise partnership could shake up the HIV drug market.

Source Fool.com

Like: 0

MRK

Share